Eyes Home > Ranibizumab Injection for Macular Degeneration

Wet macular degeneration is a serious eye condition associated with aging. The most commonly used treatments for this condition include things like:
Ranibizumab (Lucentis®) is one of the injections used for wet macular degeneration. It is injected directly into the affected eye once a month.
In clinical studies, ranibizumab injections were compared to placebo injections (injections without any active ingredient) or to a certain type of photodynamic therapy (PDT) commonly used to treat the condition. Ranibizumab was shown to be significantly more effective than placebo injections or PDT. In fact, up to 40 percent of those receiving injections for a year had significant vision improvement, compared to just 5 percent for placebo and 6 percent for PDT.
(Click What Is Ranibizumab Used For? to learn more. This article takes a closer look at using this drug for macular degeneration and also describes the other eye conditions it is approved to treat.)
Written by/reviewed by:
Last reviewed by: Arthur Schoenstadt, MD
Last updated/reviewed:
List of references (click here):
Other Articles in This eMedTV Presentation




Related Channels

eMedTV Links
Copyright © 2006-2018 Clinaero, Inc.

eMedTV serves only as an informational resource. This site does not dispense medical advice or advice of any kind. Site users seeking medical advice about their specific situation should consult with their own physician. Click Terms of Use for more information.

This site complies with the HONcode standard for trustworthy health information:
verify here.